Search by Drug Name or NDC

    NDC 00006-4096-02 VAQTA 50 [iU]/mL Details

    VAQTA 50 [iU]/mL

    VAQTA is a INTRAMUSCULAR INJECTION, SUSPENSION in the VACCINE category. It is labeled and distributed by Merck Sharp & Dohme LLC. The primary component is HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED).

    Product Information

    NDC 00006-4096
    Product ID 0006-4096_261399ed-0541-4663-84c7-fef1bcd0bcf4
    Associated GPIs 17100008001870
    GCN Sequence Number 062812
    GCN Sequence Number Description hepatitis A virus vaccine/PF SYRINGE 50 UNIT/ML INTRAMUSC
    HIC3 W7B
    HIC3 Description VIRAL/TUMORIGENIC VACCINES
    GCN 98583
    HICL Sequence Number 034417
    HICL Sequence Number Description HEPATITIS A VIRUS VACCINE/PF
    Brand/Generic Brand
    Proprietary Name VAQTA
    Proprietary Name Suffix n/a
    Non-Proprietary Name hepatitis A vaccine, inactivated
    Product Type VACCINE
    Dosage Form INJECTION, SUSPENSION
    Route INTRAMUSCULAR
    Active Ingredient Strength 50
    Active Ingredient Units [iU]/mL
    Substance Name HEPATITIS A VIRUS STRAIN CR 326F ANTIGEN (FORMALDEHYDE INACTIVATED)
    Labeler Name Merck Sharp & Dohme LLC
    Pharmaceutical Class Actively Acquired Immunity [PE], Hepatitis A Vaccines [CS], Inactivated Hepatitis A Virus Vaccine [EPC], Vaccines, Inactivated [CS]
    DEA Schedule n/a
    Marketing Category BLA
    Application Number BLA103606
    Listing Certified Through 2024-12-31

    Package

    NDC 00006-4096-02 (00006409602)

    NDC Package Code 0006-4096-02
    Billing NDC 00006409602
    Package 10 SYRINGE in 1 CARTON (0006-4096-02) / 1 mL in 1 SYRINGE (0006-4096-01)
    Marketing Start Date 1996-03-29
    NDC Exclude Flag N
    Pricing Information N/A